Chemical Approaches for RNAi Drug Development

DOI Web Site Web Site PubMed 32 References

Bibliographic Information

Other Title
  • RNA干渉創薬の実現へ向けたケミカルアプローチ
  • Review for award : RNA干渉創薬の実現へ向けたケミカルアプローチ
  • Review for award : RNA カンショウソウヤク ノ ジツゲン エ ムケタ ケミカルアプローチ

Search this article

Abstract

<p>RNA interference (RNAi) is the standard method of suppressing gene expression because of its target specificity, potency, and ability to silence the expression of virtually any gene. Using 21-mer small interfering RNA (siRNA) is the general approach for inducing RNAi, as siRNA can be easily prepared using a DNA/RNA synthesizer. Synthetic siRNA can be chemically modified to increase the potency of RNAi activity and abrogate innate immune stimulation. However, designing chemically modified siRNA requires substantial experimentation. A practical method for understanding the interaction of siRNA and RNAi-related proteins and how modifications affect RNA-protein interactions is therefore needed. Plasmid DNA (pDNA) expressing short hairpin RNA (shRNA) can also be used to induce RNAi. pDNA produces numerous shRNAs that induce RNAi with potent and longterm RNAi activity, even if only one pDNA molecule is delivered to the nucleus. However, this approach has some drawbacks with regard to its therapeutic application, such as a low pDNA transfection efficiency due to its huge molecular size and innate immune responses induced by extra genes, such as CpG motifs. To overcome these issues with RNAi inducers (siRNA and pDNA), our group developed some chemical approaches using chemically modified oligonucleotides. This article focuses on our two original approaches. The first involves the groove modification of siRNA duplexes to understand siRNA-protein interactions using 7-bromo-7-deazaadenosine and 3-bromo-3-deazaadenosine as chemical probes, while the second involves the generation of RNAi medicine using chemically modified DNA, known as an intelligent shRNA expression device (iRed).</p>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 140 (10), 1259-1268, 2020-10-01

    The Pharmaceutical Society of Japan

References(32)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top